BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10252492)

  • 1. The retainer fee contract.
    Schoen I
    Pathologist; 1981 Aug; 35(8):438-9. PubMed ID: 10252492
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathologist fee crisis--Rx for relief.
    Healy MI
    Case Stud Health Adm; 1980; 2():312-6. PubMed ID: 10250519
    [No Abstract]   [Full Text] [Related]  

  • 3. Hospitals can pull in extra 5% profit by marketing their slack lab capacity.
    Nathanson M
    Mod Healthc; 1983 May; 13(5):64, 67. PubMed ID: 10260321
    [No Abstract]   [Full Text] [Related]  

  • 4. Directing the post-TEFRA laboratory.
    Sharp JW
    Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negotiating your contract: points to consider.
    Zeiler WB
    Pathologist; 1984 Sep; 38(9):568-71. PubMed ID: 10273569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COBRA coils for strike against clinical lab fees.
    MLO Med Lab Obs; 1986 Jun; 18(6):25-6. PubMed ID: 10300963
    [No Abstract]   [Full Text] [Related]  

  • 7. How to manage under prospective payment.
    Sisk FA
    MLO Med Lab Obs; 1987 Apr; 19(4):71-4. PubMed ID: 10312034
    [No Abstract]   [Full Text] [Related]  

  • 8. Slow lab computer market picks up.
    LaViolette S
    Mod Healthc; 1979 Nov; 9(11):46, 48. PubMed ID: 492117
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenge of catastrophe.
    Dorsey DB
    Pathologist; 1978 Sep; 32(9):564-7. PubMed ID: 10308711
    [No Abstract]   [Full Text] [Related]  

  • 10. Zero base approach to fiscal management of the laboratory.
    Boudreau DA; Majonos JS
    Pathologist; 1985 Aug; 39(8):14-8. PubMed ID: 10272519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologists to challenge Medicare rule.
    Lewis R
    Am Med News; 1983 Apr; 26(14):1, 19. PubMed ID: 10324806
    [No Abstract]   [Full Text] [Related]  

  • 12. The flexible budget process--a tool for cost containment.
    Pearson JR; Romfh PC; Habib JM; Frieling MJ
    Am J Clin Pathol; 1985 Aug; 84(2):202-8. PubMed ID: 4025225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal considerations in pathologists' contracting-recent developments.
    Polk LT
    Pathologist; 1981 May; 35(5):268-71. PubMed ID: 10251158
    [No Abstract]   [Full Text] [Related]  

  • 14. What the regulatory developments mean for pathologist-hospital contracts.
    Bierig JR; Dechene JC
    Pathologist; 1984 Sep; 38(9):562-7. PubMed ID: 10273568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologists hope HHS clarification will give them leverage with hospitals.
    Wallace C
    Mod Healthc; 1984 Jun; 14(8):28, 30. PubMed ID: 10273518
    [No Abstract]   [Full Text] [Related]  

  • 16. Modes of compensation of pathologists and the charges for and use of laboratory services.
    Markel SF; Rycus MJ
    JAMA; 1980 May 23-30; 243(20):2053-5. PubMed ID: 7373744
    [No Abstract]   [Full Text] [Related]  

  • 17. A cost containment checklist.
    Garcia LS
    MLO Med Lab Obs; 1985 Apr; 17(4):67-8, 71-5. PubMed ID: 10270788
    [No Abstract]   [Full Text] [Related]  

  • 18. The coming of Medicare--a turbulent time for pathology: Part II.
    Coleman FC
    Pathologist; 1981 May; 35(5):272-6. PubMed ID: 10298172
    [No Abstract]   [Full Text] [Related]  

  • 19. Dr. Derman testifies on MD-DRGs.
    Derman H
    Pathologist; 1986 Aug; 40(8):51-4. PubMed ID: 10311691
    [No Abstract]   [Full Text] [Related]  

  • 20. What the new Medicare rules mean to pathologists.
    Cole GW
    MLO Med Lab Obs; 1983 May; 15(5):50-4. PubMed ID: 10299168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.